Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin’s lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19)

✍ Scribed by M. Herold; A. Schulze; D. Niederwieser; A. Franke; H. J. Fricke; P. Richter; M. Freund; B. Ismer; K. Dachselt; C. Boewer; V. Schirmer; J. Weniger; R. Pasold; C. Winkelmann; C. Klinkenstein; M. Schulze; H. Arzberger; K. Bremer; S. Hahnfeld; A. Schwarzer; C. Müller; Chr. Müller; for the East German Study Group Hematology and Oncology (OSHO)

• Publisher: Springer-Verlag
• Year: 2005
• Tongue: English
• Weight: 313 KB
• Volume: 132
• Category: Article
• ISSN: 1432-1335
• DOI: 10.1007/s00432-005-0023-2